首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Molecular Oncology

Molecular Oncology杂志,由John Wiley and Sons Ltd出版,于2007年创刊,Quarterly,出版语言English,ISSN:1878-0261,E-ISSN:1878-0261。

投稿咨询
Molecular Oncology
Molecular Oncology
Molecular Oncology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
2区
影响因子
4.5
CiteScore
9.4
期刊收录
SCI、SCIE

Molecular Oncology(中文译名:《分子肿瘤学》),ISSN:1878-0261,EISSN:1878-0261,是John Wiley and Sons Ltd出版的国际性学术期刊,创刊于2007年,以Quarterly形式稳定发行,2026年总发文量约183篇。该刊采用OA开放访问,学科归属为Biochemistry, Genetics and Molecular Biology - Molecular Medicine。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.5,2025年期刊CiteScore为9.4,2025年期刊自引率约2.2%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Molecular Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期10 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、GERMANY (FED REP GER)、England、Italy、Sweden、Denmark等为核心发文国家与地区;HELMHOLTZ ASSOCIATIONKAROLINSKA INSTITUTET、HARVARD UNIVERSITY、RUPRECHT KARLS UNIVERSITY HEIDELBERG、SHANGHAI JIAO TONG UNIVERSITY、DANISH CANCER SOCIETY、SUN YAT SEN UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 104 / 333

68.9

学科:ONCOLOGY SCIE Q2 91 / 333

72.82

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 67 / 322

79.3

学科:ONCOLOGY SCIE Q1 57 / 322

82.45


中国学者近期发文

1
EDNRB-dependent endothelin signaling reduces proliferation and promotes proneural-to-mesenchymal transition in glioma

Author:Pineau, Donovan; Garcia, Leonor; Arnold, Hugo; Hanzek, Antonija; Arrieta, Maialen; Gauthier, Laurent R.; Granotier-Beckers, Christine; Boussin, Francois D.; Herbet, Amaury; Hautiere, Marie; Asei-Ceschino, Valentin; Jacques, Clementin; Brard, Laura; Harnois, Thomas; Coronas, Valerie; Constantin, Bruno; Chatelier, Aurelien; Chemin, Jean; Urbach, Serge; Seveno, Martial; Hideg, Szimonetta; Ripoll, Chantal; Aguilar-Cazarez, Kasandra; Zheng, Min; Huang, Guo-Hao; Lv, Sheng-Qing; Zhang, Lei; Rondard, Philippe; Prezeau, Laurent; Pin, Jean-Philippe; Duffau, Hugues; Bauchet, Luc; Rigau, Valerie; Denat, Franck; Truillet, Charles; Boquet, Didier; Hugnot, Jean-Philippe

Journal: MOLECULAR ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70223

2
DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patient

Author:Chen, Chao; Cheng, Jiancheng; Hou, Ruili; Zheng, Xiaoyuan; Su, Li; Bjaanaes, Maria Moksnes; Karlsson, Anna; Planck, Maria; Staaf, Johan; Helland, Aslaug; Esteller, Manel; Christiani, David C.; Chen, Feng; Cao, Xiaofei; Zhang, Ruyang

Journal: MOLECULAR ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70260

3
Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis

Author:Li, Chen-xi; Gong, Zhong-cheng

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70037

4
Comprehensive omics-based classification system in adult patients with B-cell acute lymphoblastic leukemi

Author:Song, Yang; Liu, Ting; Hao, Qishan; Fang, Qiuyun; Gong, Xiaoyuan; Li, Yan; Tian, Zheng; Wei, Hui; Wang, Min; Wang, Jianxiang; Cheng, Tao; Mi, Yingchang

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70053

5
MET and NF2 alterations confer primary and early resistance to first-line alectinib treatment in ALK-positive non-small-cell lung cance

Author:Hu, Jie; Ding, Ning; Xu, Xiaobo; Chen, Yedan; Zhang, Yong; Liu, Jingwen; Zhou, Jiebai; Bao, Hairong; Zhang, Donghui; Song, Yijun; Shao, Yang; Song, Yuanlin

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70029

6
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dat

Author:Zhu, Rong; Eason, Katherine; Chin, Suet-Feung; Edwards, Paul A. W.; Manzano Garcia, Raquel; Moulange, Richard; Pan, Jia Wern; Teo, Soo Hwang; Mukherjee, Sach; Callari, Maurizio; Caldas, Carlos; Sammut, Stephen-John; Rueda, Oscar M.

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70041

7
Classification of acute myeloid leukemia based on multi-omics and prognosis prediction valu

Author:Song, Yang; Wang, Zhe; Zhang, Guangji; Hou, Jiangxue; Liu, Kaiqi; Wei, Shuning; Li, Yan; Zhou, Chunlin; Lin, Dong; Wang, Min; Wei, Hui; Wang, Jianxiang; Cheng, Tao; Mi, Yingchang

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.70000

8
CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR-15b-5p and miR-7-1-3p processing in nasopharyngeal carcinom

Author:Fan, Chunmei; Tan, Fenghua; Wu, Jie; Zeng, Zhaoyang; Guo, Wenjia; Huang, He; Xiong, Wei

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.13821

9
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cance

Author:Hu, Zuojian; Shen, Fenglin; Liu, Yang; Zhong, Ziqing; Chen, Yongling; Xia, Zhiyuan; Mo, Cuiju; Yu, Hongxiu

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.13791

10
The accumulation of myeloid-derived suppressor cells participates in abdominal infection-induced tumor progression through the PD-L1/PD-1 axi

Author:Wang, Yiding; Guo, Ting; Xing, Xiaofang; Liu, Xijuan; Gan, Xuejun; Li, Yingai; Liu, Yan; Shan, Fei; Wu, Zhouqiao; Ji, Jiafu; Li, Ziyu

Journal: MOLECULAR ONCOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/1878-0261.13767


在线咨询

Molecular Oncology

国际简称:MOL ONCOL参考译名:分子肿瘤学

年发文量:183 CiteScore:9.4 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:94.54%

杂志社联系方式:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Molecular Oncology